Satoshi Kobayashi MD, Presenter: Nothing to Disclose

Naoki Ohno PhD, Abstract Co-Author: Nothing to Disclose

Yasunari Fujinaga MD, Abstract Co-Author: Nothing to Disclose

Tosiaki Miyati PhD, Abstract Co-Author: Nothing to Disclose

Toshifumi Gabata MD, Abstract Co-Author: Nothing to Disclose

Osamu Matsui MD, Abstract Co-Author: Research Consultant, Kowa Company, Ltd Research Consultant, Otsuka Holdings Co, Ltd Research Consultant, Eisai Co, Ltd Speakers Bureau, Bayer AG Speakers Bureau, Eisai Co, Ltd

Hiroshi Ikeno, Abstract Co-Author: Nothing to Disclose

Wataru Koda, Abstract Co-Author: Nothing to Disclose

Kazuto Kozaka MD, Abstract Co-Author: Nothing to Disclose

Dai Inoue, Abstract Co-Author: Nothing to Disclose

Kotaro Yoshida MD, Abstract Co-Author: Nothing to Disclose

Norihide Yoneda, Abstract Co-Author: Nothing to Disclose

Tetsuya Minami MD, Abstract Co-Author: Nothing to Disclose

To describe the advantage and disadvantage of gadoxetic acid (Gd-EOB-DTPA, EOB) enhanced liver MRI compared to MR images with conventional Gadolinium based MR-contrast media (Gd). To demonstrate the various techniques for optimization for EOB enhanced MRI.  

1. Basic knowledge of EOB especially focused on the aspect of hepatocellular transporter function 2. Advantage and disadvantage of EOB enhanced MRI special reference to the differences with conventional Gd-enhanced MRI for hepatobiliary examination. 3. Technical aspect of optimization for EOB-enhanced MRI (1) EOB administration technique (2) Take measures for acute transient dyspnea after intravenous administration of EOB (3) Optimal flip angle for better hepatobiliary phase image acquisition (4) Consideration of super-delayed phase image acquisition to improve conspicuity of hepatic lesions Summary Although EOB might be strong tool for detection and characterization of hepatic lesion, optimization of imaging protocol for EOB enhanced MRI is essential to acquire better images and improve patients’ quality of life.  

http://abstract.rsna.org/uploads/2014/14005865/14005865_9ya4.pdf

Kobayashi, S, Ohno, N, Fujinaga, Y, Miyati, T, Gabata, T, Matsui, O, Ikeno, H, Koda, W, Kozaka, K, Inoue, D, Yoshida, K, Yoneda, N, Minami, T, Technical Aspects of Optimization for Gadoxetic Acid-enhanced Liver MR Imaging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005865.html